SCHEMBL6177799

SCHEMBL6177799

O=S(=O)(c1ccccc1)N1CCCC1c1ccc(C(F)(F)F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.64
LMNA P02545 1/20 0.59
PSEN1 P49768 1/20 0.59
PSEN2 P49810 1/20 0.59
APH1B Q8WW43 1/20 0.59
NCSTN Q92542 1/20 0.59
APH1A Q96BI3 1/20 0.59
PSENEN Q9NZ42 1/20 0.59
CYP3A4 P08684 2/20 0.55
CYP2C19 P33261 2/20 0.55
BRD4 O60885 2/20 0.55
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 1/20 0.50
MMP8 P22894 2/20 0.48
MMP3 P08254 1/20 0.48
BRD2 P25440 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177802 1.00 TRPA1 (0.64) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6182510 0.88 TRPA1 (0.84) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178961 0.88 TRPA1 (0.84) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6182506 0.88 TRPA1 (0.84) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178958 0.88 TRPA1 (0.84) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6180584 0.87 PSEN1 (0.74) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6180588 0.87 PSEN1 (0.74) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178726 0.87 TRPA1 (0.65) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178585 0.87 PSEN1 (0.67) TRPA1LMNAPSEN1PSEN2APH1B
SCHEMBL6178722 0.87 TRPA1 (0.65) TRPA1LMNAPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed